βV-tubulin expression is associated with outcome following taxane-based chemotherapy in non-small cell lung cancer
Published 2012 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
βV-tubulin expression is associated with outcome following taxane-based chemotherapy in non-small cell lung cancer
Authors
Keywords
-
Journal
BRITISH JOURNAL OF CANCER
Volume 107, Issue 5, Pages 823-830
Publisher
Springer Nature
Online
2012-07-27
DOI
10.1038/bjc.2012.324
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Gender Influences the Class III and V -Tubulin Ability to Predict Poor Outcome in Colorectal Cancer
- (2012) M. Mariani et al. CLINICAL CANCER RESEARCH
- Metastatic non-small-cell lung cancer: consensus on pathology and molecular tests, first-line, second-line, and third-line therapy: 1st ESMO Consensus Conference in Lung Cancer; Lugano 2010
- (2011) E. Felip et al. ANNALS OF ONCOLOGY
- Class III -Tubulin in Advanced NSCLC of Adenocarcinoma Subtype Predicts Superior Outcome in a Randomized Trial
- (2011) A. C. Vilmar et al. CLINICAL CANCER RESEARCH
- Class V β-tubulin alters dynamic instability and stimulates microtubule detachment from centrosomes
- (2011) Rajat Bhattacharya et al. MOLECULAR BIOLOGY OF THE CELL
- The proof and measurement of association between two things
- (2010) C Spearman INTERNATIONAL JOURNAL OF EPIDEMIOLOGY
- Expression of ERCC1 and class III β-tubulin in non-small cell lung cancer patients treated with a combination of cisplatin/docetaxel and concurrent thoracic irradiation
- (2009) Koichi Azuma et al. CANCER CHEMOTHERAPY AND PHARMACOLOGY
- The New Lung Cancer Staging System
- (2009) Frank C. Detterbeck et al. CHEST
- Molecular Basis for Class V β-Tubulin Effects on Microtubule Assembly and Paclitaxel Resistance
- (2009) Rajat Bhattacharya et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Differences in the Expression Profiles of Excision Repair Crosscomplementation Group 1, X-Ray Repair Crosscomplementation Group 1, and βIII-Tubulin Between Primary Non-small Cell Lung Cancer and Metastatic Lymph Nodes and the Significance in Mid-Term Survival
- (2009) Chang Hyun Kang et al. Journal of Thoracic Oncology
- The prognostic significance of ERCC1, BRCA1, XRCC1, and βIII-tubulin expression in patients with non-small cell lung cancer treated by platinum- and taxane-based neoadjuvant chemotherapy and surgical resection
- (2009) Chang Hyun Kang et al. LUNG CANCER
- New response evaluation criteria in solid tumours: Revised RECIST guideline (version 1.1)
- (2008) E.A. Eisenhauer et al. EUROPEAN JOURNAL OF CANCER
- Expression of excision repair cross-complementation group 1 and class III β-tubulin predict survival after chemotherapy for completely resected non-small cell lung cancer
- (2008) Katsuhiro Okuda et al. LUNG CANCER
- Expression of ERCC1 and class III β-tubulin in non-small cell lung cancer patients treated with carboplatin and paclitaxel
- (2008) Koichi Azuma et al. LUNG CANCER
- Localization of βv tubulin in the cochlea and cultured cells with a novel monoclonal antibody
- (2008) Asok Banerjee et al. CELL MOTILITY AND THE CYTOSKELETON
- A minor β-tubulin essential for mammalian cell proliferation
- (2008) Rajat Bhattacharya et al. CELL MOTILITY AND THE CYTOSKELETON
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now